37 Views | 9 Downloads
Parag H. Joshi, MD MHS, Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, E5.730F, Dallas, Texas 75390-8830, Tel: 214-645-8000, Fax: 214-645-2480. Email: parag.joshi@utsouthwestern.edu
The authors thank the other investigators, the staff, and the participants of the MESA and DHS for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.
A.M. is supported by American Heart Association postdoctoral fellowship award 19POST34400057 and by Abraham J. & Phyllis Katz foundation. P.H.J. has received grant support from the American Heart Association, Novo Nordisk, Sanofi/Regeneron, GlaxoSmithKline, AstraZeneca, and Pfizer and personal fees from Bayer and Regeneron; equity interest in Global Genomics Group. Rest of the authors have no disclosures.
The MESA study is supported by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the NHLBI, and by grants UL1-TR-000040,UL1-TR-001079, and UL1-TR-001420 from National Center for Advancing Translational Sciences. The DHS was funded by the Donald W. Reynolds Foundation, Las Vegas, Nevada, and partially supported by the National Center for Advancing Translational Sciences of the NIH under award Number UL1TR001105.